Annex 1 at ISPE Europe Annual Conference

We are pleased to be exhibiting and speaking at this year’s event which will take place from  April 25th to 27th in Madrid and virtually. Our experts will  focus on the changing pharmaceutical space in relation to Annex 1.

Alf Penfold, GMP and Regulatory SME, PM Group, will discuss how we can accommodate multiple modalities in the same facility, including Cell and Gene therapies. “Advanced Therapy Medicinal Products (ATMP) facilities are different to the more conventional pharmaceutical facilities. My talk will focus on the required segregation these facilities need in compliance with Annex 1”, said Alf.

Another factor that Annex 1 could impact is sustainability. Craig Milner, Process Engineer, PM Group, will explore how and if we are able to reduce our carbon footprint, while maintaining such compliance.

Meet our speakers at Booth 15, and our Single Use SME Javier Lozano, who will be  booth 59, supporting the SDD^TM initiative.

Click here to register.